Potassium channel
Showing 1 - 25 of 1,512
Headache, Migraine With Aura, Migraine Without Aura Trial in Copenhagen (Levcromakalim)
Recruiting
- Headache
- +2 more
-
Copenhagen, Glostrup, DenmarkDanish headache center
Sep 29, 2022
Essential Hypertension Trial (Azilsartan Medoxomil Potassium Tablet, Nifedipine Sustained -release Tablets, Levoamlodipine
Not yet recruiting
- Essential Hypertension
- Azilsartan Medoxomil Potassium Tablet
- +2 more
- (no location specified)
Jul 21, 2023
Genetic Study for Infantile Onset Diabetes Mellitus
Active, not recruiting
- Gene Mutation in Infantile Onset Diabetes Mellitus
-
Assiut, EgyptAssiut University Hospital
Feb 17, 2022
Myoclonus Epilepsies, Progressive Trial in Philadelphia (AUT00201, Placebo)
Recruiting
- Myoclonus Epilepsies, Progressive
- AUT00201
- Placebo
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania, Penn Epilepsy Center
May 15, 2023
Drug Resistant Epilepsy Trial (lentiviral gene therapy)
Not yet recruiting
- Drug Resistant Epilepsy
- lentiviral gene therapy
- (no location specified)
May 17, 2022
Potassium Sodium-Activated Channel Subfamily T Member 1-Related
Active, not recruiting
- KCNT1-Related Epilepsy
- No Intervention
-
Rochester, New YorkUniversity of Rochester
Jan 12, 2023
Preterm Labor With Preterm Delivery Trial in Egypt (Potassium Channel Opener, Calcium channel blocker)
Recruiting
- Preterm Labor With Preterm Delivery
- Potassium Channel Opener
- Calcium channel blocker
-
Egypt, Alexandria, EgyptManella Fayez Zaki Beshara
Apr 13, 2021
Hypertension Trial (losartan potassium (+ hydrochlorothiazide [HCTZ] + calcium channel blocker [CCB]), Low Salt Diet)
Completed
- Hypertension
- losartan potassium (+ hydrochlorothiazide [HCTZ] + calcium channel blocker [CCB])
- Low Salt Diet
- (no location specified)
Feb 7, 2022
Autoimmune Epilepsy Trial in Rochester (Intravenous Immunoglobulin, Placebos, Normal Saline)
Terminated
- Autoimmune Epilepsy
- Intravenous Immunoglobulin
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Dec 12, 2019
Neonatal Diabetes Secondary to Mutation in the Potassium Channel Trial in Paris (Glibenclamide)
Completed
- Neonatal Diabetes Secondary to Mutation in the Potassium Channel
-
Paris, FranceHôpital Universitaire Necker Enfants Malades
Aug 29, 2019
Cystic Fibrosis-related Diabetes, Cystic Fibrosis Trial in Kansas City (Metformin Hydrochloride)
Recruiting
- Cystic Fibrosis-related Diabetes
- Cystic Fibrosis
- Metformin Hydrochloride
-
Kansas City, KansasUniversity of Kansas Medical Center
Mar 1, 2022
Long QT Syndrome Trial in Rochester (Placebo, Ranolazine)
Completed
- Long QT Syndrome
- Placebo
- Ranolazine
-
Rochester, New YorkUniversity of Rochester
Mar 15, 2022
's Study of a Smartphone Application for Periodic Paralysis
Recruiting
- Periodic Paralyses
-
Paris, Île-de-France, FranceRaDiCo-PP
Jul 26, 2023
Novel Antineuronal Antibodies in Gastrointestinal Motility
Recruiting
- Autoimmune Gastrointestinal Dysmotility
- Blood sample collection
-
Baltimore, MarylandJohns Hopkins Bayview Medical Center
Mar 8, 2022
Atrial Fibrillation, Cardiac Arrhythmia Trial in Basel, Bern, Solothurn (Colchicine, Placebo)
Not yet recruiting
- Atrial Fibrillation
- Cardiac Arrhythmia
- Colchicine
- Placebo
-
Basel, Switzerland
- +2 more
Jun 5, 2023
Primary Aldosteronism, Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral) Trial in Boston (Amlodipine)
Recruiting
- Primary Aldosteronism
- Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral)
-
Boston, MassachusettsAnand Vaidya
Nov 26, 2021
Prognosis of Neonatal KCNQ2 Gene-associated Epileptic
Recruiting
- Seizures
- +7 more
- KCNQ2
-
Shanghai, Shanghai, ChinaChildren Hospital of Fudan University
Jan 3, 2022
Magnesium, Intraoperative Analgesia Trial (Magnesium Sulfate, Propofol)
Not yet recruiting
- Magnesium
- Intraoperative Analgesia
- Magnesium Sulfate
- Propofol
- (no location specified)
Nov 12, 2023
New Onset Atrial Fibrillation, Complications; Cardiac, Postoperative Trial (Nifekalant, Amiodarone)
Not yet recruiting
- New Onset Atrial Fibrillation
- Complications; Cardiac, Postoperative
- (no location specified)
Feb 2, 2022
Obesity Trial in Madison (Drug Trial 1 (EDD), Drug Trial 2 (ROV))
Terminated
- Obesity
- Drug Trial 1 (EDD)
- Drug Trial 2 (ROV)
-
Madison, WisconsinUniversity of Wisconsin, Madison
Jan 28, 2022
MDD Trial in United States (XEN1101 10 mg, XEN1101 20 mg, Placebo)
Recruiting
- Major Depressive Disorder
- XEN1101 10 mg
- +2 more
-
Lafayette, California
- +5 more
Jul 11, 2022